GAPVAC at the EANO conference (Oct 10-14) in Stockholm, Sweden
Prof. Pierre-Yves Dietrich, Co-lead Investigator of the GAPVAC-101 trial and Director of the Centre of Oncology at the Geneva University Hospital, to present results from the GAPVAC trial at EANO conference (Oct 10-14) in Stockholm:
October 12, 11:27am-11:39am
Oral Session 2: Non-surgical treatment (Room: A2)
"Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial"
We're looking forward to interesting and exciting discussions.
Further information on EANO here.